The Treatment Choice Based on Radiographic Features for Metastatic Brain Tumors in ALK-Rearranged Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.06.1824
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Importance of Molecular Features of Non–Small Cell Lung Cancer for Choice of Treatment

American Journal of Pathology
Forensic MedicinePathology
2011English

New Options in the Management of Intractable ALK(+) Metastatic Non-Small-Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2014English

ASCEND-2: A Canary in a Coal Mine for Descending to Second-Line Treatment for ALK-rearranged Non-Small Cell Lung Cancer

Translational Lung Cancer Research
Oncology
2016English

The Biology and Treatment of EML4-ALK Non-Small Cell Lung Cancer

European Journal of Cancer
Cancer ResearchOncology
2010English

Brigatinib for ALK-positive Metastatic Non-Small-Cell Lung Cancer: Design, Development and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Unmet Needs in the Treatment of Metastatic Non-Small-Cell Lung Cancer

European Oncology and Haematology
OncologyHematology
2008English

P2.15-10 Determinants of Health Utility Scores (HUS) in Patients With ALK Rearranged Non-Small Cell Lung Cancer.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

P2.01-50 Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy